Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Stroboscopic light source for a transmitter of a large scale metrology system
Carrier for developing electrostatic charge image, developer for developing electrostatic charge image, image forming apparatus, and image forming method
Area reduction for surface mount package chips
Secure device sharing
Low-complexity motion vector prediction systems and methods
Methods of modulating interleukin-22 and immune response by notch regulators
Fixing apparatus
  Randomly Featured Patents
Fetal pulse oximetry apparatus and method of use
Automatic apparatus for pick-up sewing of curved edges of a fabric piece on clothing
Portion of a roller skate
Shoulder mounted device with eye-confronting portion forwardly of a user's eyes
Electrochromic layer and devices comprising same
Tension locking mechanism of a retractor
Fortification of soft drinks with protein
Pixel interval compensating method
Multi-part modular airfoil section and method of attachment between parts